Category : Ulcerative Colitis

Infliximab Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Infliximab for Induction and Maintenance Therapy ..

Read more

Vedolizumab vs Adalimumab Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative ..

Read more

Vedolizumab Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Vedolizumab as Induction and Maintenance Therapy ..

Read more

Mild to moderate Ulcerative Colitis: 5-ASA efficacy and dosage A Cochrane review: Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis 5-ASA vs placebo for induction of remission in Ulcerative Colitis High dose 5-ASA vs low dose 5-ASA for induction in Ulcerative Colitis Author’s conclusions: 5-ASA was superior to placebo and no more effective ..

Read more

Several diagnostic and treatment algorithms for pouchitis Pouchitis disease activity index: Pouchitis diagnostic algorithm Shen 2013 Clin Gastroenterol Hepatol. Pouchitis treatment algorithm. Shen 2013 Clin Gastroenterol Hepatol. Alternative treatment algorithm (reference?) Segal et al. Systematic Review With Meta-Analysis: The Management of Chronic Refractory Pouchitis With an Evidence-Based Treatment Algorithm. Aliment Pharmacol Ther Actions 2017 Nguyen ..

Read more

Cumulative risk of main outcomes on Left sided Ulcerative Colitis phenotype, disease activity and Colorectal Cancer. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Results taken from the abstract of the article Left-sided colitis is the most frequent location, and disease extension is observed in 10%–30% of patients. Majority of patients ..

Read more

Mild-to-moderate Ulcerative Colitis induction therapy: budesonide (CORE studies) Once-daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study William J Sandborn, Simon Travis, Luigi Moro , Richard Jones, Theres Gautille, Robert Bagin , Michael Huang, Phil Yeung, E David Ballard Background & aims: Budesonide is a corticosteroid with minimal systemic corticosteroid activity ..

Read more

Infliximab with Azathiopurine in Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Infliximab Azathiopurine combination therapy in ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Adalimumab for induction of clinical remission in moderately to severely active ulcerative ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Meta-analysis MTX (methotrexate) vs placebo in maintenance ulcerative colitis. The ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis (2017) ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Cochrane analysis comparing probiotics and mesalazine as maintenance treatment in ..

Read more

BOUGUEN, G., ROBLIN, X., BOURREILLE, A., FEIER, L., FILIPPI, J., NANCEY, S., … PEYRIN-BIROULET, L. (2010). Infliximab for refractory ulcerative proctitis. Alimentary Pharmacology & Therapeutics, 31(11), 1178–1185. doi:10.1111/j.1365-2036.2010.04293.x BACKGROUND: Efficacy of infliximab in treating ulcerative proctitis remains unknown. AIM: To evaluate the clinical, biological and endoscopic efficacy of infliximab therapy in refractory proctitis. METHODS: The ..

Read more

Mallet, A.-L., Bouguen, G., Conroy, G., Roblin, X., Delobel, J.-B., Bretagne, J.-F., … Peyrin-Biroulet, L. (2017). Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study. Digestive and Liver Disease, 49(3), 280–285. doi:10.1016/j.dld.2016.12.001 BACKGROUND: Efficacy of azathioprine (AZA) in refractory ulcerative proctitis (UP) is unknown. METHODS: All patients treated with AZA for refractory UP in three ..

Read more

Lawrance, I. C., Baird, A., Lightower, D., Radford-Smith, G., Andrews, J. M., & Connor, S. (2017). Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. Clinical Gastroenterology and Hepatology, 15(8), 1248–1255. doi:10.1016/j.cgh.2017.02.027 BACKGROUND & AIMS: Resistant ulcerative proctitis can be extremely difficult to manage. Topically administered tacrolimus, however, may be effective ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Sands BE, Sandborn WJ, Panaccione R, et al. Ustekinumab ..

Read more

Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis) Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant ..

Read more